Iproteos, one of the 5 spin-offs launched by IRB Barcelona, focuses on the development of third-generation drugs for diseases such as schizophrenia, epilepsy, and atherosclerosis.
Its proprietary technology allows faster research processes to identify new drugs and produce novel molecules.
The new company Accure Therapeutics starts up with €7.6 M of investment, which will allow the development of its product portfolio and the takeover of Iproteos and Bionure.
The Center for Genomic Regulation (CRG), the National Center for Genomic Analysis (CNAG-CRG), part of CRG, the Institute for Research in Biomedicine (IRB Barcelona) and the Institute for Bioengineering of Catalonia (IBEC) have analysed more than 20,000 samples to date using the PCR technique. In this regard, 17,547 samples have been tested at the CRG node and 5,248 at the PCB node.
The analyses are part of the Orfeu Programme, the mass screening initiative driven by the Government of Catalonia. As of today, the public health system in Catalonia can carry out up to 17,000 PCR tests every day. This number does not include the capacity of the Orfeu Programme, which can process up to...
The Chemical Checker provides processed, harmonized and ready-to-use bioactivity information on more than 1M small molecules
The tool, developed by the Structural Bioinformatics and Network Biology lab at IRB Barcelona, has been published in Nature Biotechnology.
Researchers at IRB Barcelona discover a new mechanism in estrogen receptor-positive breast cancer cells.
The inhibition of CPEB2, a key factor in the estrogen signalling pathway, causes cancer cells to proliferate less and protects mice against luminal breast cancer.
The Colorectal Cancer Lab at IRB Barcelona identifies the capacity to synthesize proteins (or biosynthetic capacity) as a key property for the regenerative potential of colon cancer cells.
Published in Cell Stem Cell, the study proposes a new therapeutic focus for the scientific community and the pharmaceutical industry to explore.
The global pandemic that we are living poses a major challenge for society at all levels. In these moments of uncertainty, IRB Barcelona has put what it knows best, cutting-edge research, at the service of the public.
IRB Barcelona’s efforts are focused on two lines of action. The first is participation in the mass PCR-based screening initiative of the Orfeu Programme, driven by the Government of Catalonia, in collaboration with the research centres CRG, IBEC and CNAG.
The second line of action is the research...
Committed to fostering gender equality policies, IRB Barcelona participates in the EU-funded CALIPER to implement a Gender Equality Plan and thus fulfil gender mainstreaming as a strategy of organisational development.
In order to prevent gender discrimination in scientific institutions, CALIPER aims to promote a universal methodology that provides permanent support for gender equality.
More than 200 regions (amino acids) in histones are identified as responsible for regulating the response to cell stress.
The study reports that histones undergo distinct modifications depending on the type of cell stress.
The work by the Cell Signaling laboratory has been published in the journal Nucleic Acids Research.
The ALBA Synchrotron will host two new major experimental facilities, one dedicated to materials science, valued at 4.1 million euros and led by the Catalan Institute of Nanoscience and Nanotechnology (ICN2), and another meant for molecular biology, valued at 1.7 million euros and headed by the Institute of Molecular Biology of Barcelona (IBMB-CSIC).
The new platform also counts with the participation of the Barcelona Institute of Science and Technology (BIST), the Spanish Council for Scientific Research (CSIC), the Institute for Biomedical Research (IRB Barcelona), the Autonomous University of Barcelona (UAB), the Institute of Materials Science of Barcelona (ICMAB-CSIC) and the Centre for Genomic Regulation (CRG).
Today, the approval of the co-financing through the European Regional Development Fund (ERDF) of these two projects, which involve numerous institutions and research centres, has been made public.